BLOOD GLUCOSE TEST STRIPS MARKET SIZE TO CROSS USD 13 BILLION BY 2026, GROWING AT A CAGR OF 6% DURING THE FORECAST PERIOD

Blood Glucose Test Strips Market Size, Share, Trends Analysis Report by Technology (Glucose Dehydrogenase (GDH) and Glucose Oxidase (GOD)), Distribution Channel (Online and Offline), End-user (Individuals, Hospitals & Clinics, and Others), and Geography (North America, Europe, APAC, Latin America, and Middle East & Africa), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021–2026

GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

317 Pages

119 Tables

192 Charts

5 Regions

20 Countries

33 Companies

4 Market Segment

GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET REPORT SCOPE

Report Attribute Details
MARKET SIZE (REVENUE) 13 BILLION (2026)
MARKET SIZE (VOLUME) 35 BILLION UNITS (2026)
CAGR 6% (2021–2026)
Base Year 2020
Forecast Year 2021-2026
Market Segments Technology (Glucose Dehydrogenase (GDH) and Glucose Oxidase (GOD)), Distribution Channel (Online and Offline), End-user (Individuals, Hospitals & Clinics, and Others)
Geographic Analysis North America, Europe, APAC, Latin America, and Middle East & Africa
Countries Covered US, Canada, UK, Germany, France, Italy, Spain, China, Japan, South Korea, Australia, India, Brazil, Mexico, Argentina, Columbia, Saudi Arabia, Turkey, South Africa, Iran, and UAE

INDUSTRY INSIGHTS

The global blood glucose test strips market size to cross USD 13 billion by 2026, growing at a CAGR of over 6% during the forecast period. The global market is one of the major segments of the diagnostics market and is growing at a steady rate during the forecast period. The surge in market growth can be attributed to the increasing prevalence/incidence of diabetes worldwide. However, the outbreak of the COVID-19 pandemic has immensely contributed to the growth of the market. According to the CDC research, diabetic people infected with the COVID-19 virus have a higher mortality rate than non-diabetic patients. France, Spain, and several other countries across Europe have witnessed high mortality among people suffering from diabetes. Meanwhile, test strips are witnessing higher growth as more people prefer self-monitoring of blood glucose at home. With the outbreak of the pandemic, the online sales of blood glucose monitoring devices and consumables such as test strips have increased. However, the impact of COVID-19 is not expected to have a long-term effect on the glucose monitoring test strips market. There is a surge in the uptake of technologically advanced test strips, which, in turn, expects to increase the adoption of these devices.

SNIPPETS

  • Glucose dehydrogenase-based test strips are likely to observe an incremental growth of over 11 billion units by 2026.
  • Online test strips sales expect to witness an incremental growth of approx. 8 billion units by 2026 due to the increasing popularity of online stores and the outbreak of the COVID-19 pandemic.
  • Individual test strips expect to reach over USD 10 billion by 2026 due to the wide acceptance of self- blood glucose devices, especially in developed countries.
  • In terms of volume, APAC is likely to observe a unit shipment of over 12 billion by 2026 due to the high diabetic population and increased usage of self-monitoring blood glucose devices.
  • North America expects to lead the market and is likely to contribute a revenue of over USD 4.5 billion by 2026.

GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SEGMENTATION

This research report includes a detailed segmentation by

  • Technology
  • End-users
  • Distribution Channel
  • Geography

INSIGHTS BY TECHNOLOGY  

The glucose dehydrogenase (GDH) test strips account for 70% of the market share. High accuracy in measuring blood glucose levels has positively affected the usage of self-monitoring blood glucose (SMBG) devices, especially in critical care settings. GDH tests strip are free from oxygen, galactose, and maltose interfaces, thereby measuring sugar levels accurately in the human blood. This has increased the demand for GDH among end-users. Moreover, increased emphasis to prevent hypoglycemia among patients is increasing the acceptance of SMBG in critical care settings.

In terms of units, the glucose oxidase (GOD) segment expects to reach over 10 billion units by 2026, growing at a CAGR of over 8%. GOD-based test strips are widely applied in hospitals, outpatient departments, emergency rooms, ambulatory medical care, and at homes as they offer high features and capacities for better diabetic management. GOD-based test strips provide better accuracy in blood glucose than laboratory testing, which further increases the adoption among end-users.

INSIGHTS BY END-USERS

The individual blood glucose test strips market is likely to reach over 27 billion units by 2026, growing at a CAGR of over 10%. The usage of test strips based on SMBGD is high among individual users in developing and developed countries. During the outbreak of the COVID-19 pandemic, the usage of blood glucose devices has increased, which has influenced the demand for test strips. The hospitals & clinics segment is likely to observe the unit shipments of approx. 6 billion units by 2026, growing at a CAGR of approx. 8%. Hospitals and clinics purchase test strips in a large volume via group purchase organizations. With the outbreak of the COVID-19 pandemic, these have become widely used devices in hospitals and ambulatory settings for detecting hyperglycemia, hypoglycemia, and glycemic variabilities. Moreover, the introduction of favorable government initiatives and reimbursement options for BGM to promote POC diagnostic tests over clinical diagnostic tests is fueling the market’s growth.

INSIGHTS BY DISTRIBUTION CHANNEL 

Offline channels expect to reach over USD 7 billion by 2026, growing at a CAGR of approx. 5%. Offline channels constitute a significant medium of sales in developing and underdeveloped countries. The offline store segment includes hospital pharmacies, standalone pharmacies, and other pharmacies. Most consumers prefer retail stores for purchase. Around 80% of sales take place through retail channels in low- and middle-income countries. In 2020, the online segment accounted for over 39% of the global blood glucose test strips market share. Global companies are strategizing impressive e-commerce strategies and developing direct patient interaction and distribution. For instance, Abbott launched its web shop to sell its products online, and it was a successive step in the distribution of blood glucose diagnostic products, including test strips.

INSIGHTS BY GEOGRAPHY

In terms of volume, the APAC blood glucose test strips market is likely to reach approx. 4 billion units by 2026, growing at a CAGR of over 11%. In the APAC region, the growing population and the high prevalence of diabetes are the major contributors to the market growth. However, the usage of blood glucose test devices in the region is limited due to the high cost and lack of reimbursement. North America is likely to lead the market by revenue. The US region occupies a significant market share as glucose test strips utilization is high in the region. Moreover, the availability of medical reimbursement and the presence of well-established healthcare infrastructure further increase the growth of the market.

INSIGHTS BY VENDORS

The global blood glucose test strips market is intensely competitive, subject to rapid technological changes, and significantly affected by new product introductions and other market activities of industry participants. F. Hoffmann-La Roche’s Diabetes Care, LifeScan, Abbott’s Diabetes Care Division, and Ascensia Diabetes Care are the major player. Currently, these companies collectively account for significant blood glucose test strips market share. These players account for a substantial stake in the market. However, they are facing stiff competition from local and regional players.

The global blood glucose test strips market research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments

Technology

  • Glucose Dehydrogenase (GDH)
  • Glucose Oxidase (GOD)

Distribution Channel

  • Online
  • Offline

End-user

  • Individuals
  • Hospitals & Clinics
  • Others

Geography

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
  • APAC
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • Latin America
    • Mexico
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • Saudi Arabia
    • Turkey
    • South Africa
    • Iran

Frequently Asked Questions

The global glucose test strips market expects to reach over USD 13 billion by 2026.
Test strips help patients to monitor blood glucose levels constantly.
The global blood glucose dehydrogenase test strip is likely to reach approx. USD 10 billion by 2026, growing at a CAGR of over 7% during the forecast period.
The global glucose test strips market is segmented by technology, distribution channels, end-users, and geography.
APAC expects to account for the largest share in the global market in terms of unit shipment.
Abbott, F. Hoffmann-La Roche, Ascensia Diabetes Care Holding, and LifeScan are the top players.
Download Free Sample
Read More

Select a license type that suits your business needs

Single User Licence
$3375.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5 User Licence
$3825.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Corporate Licence
$4725.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Datasheet Licence
$1350.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Select a license type that suits your business needs

Best Value Tag
Coming Soon
  • Stay tuned with us.

YOU CAN GET A FREE SAMPLE OF THIS REPORT!

Fill out your details & get your free sample

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Our Clients

10%

Off

FLASH SALE

DAYS

HOURS

MINUTES

SECONDS

Licence Types What are these?

Our Clients Speak

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date